Phesgo Injection, Solution
Product Images NDC 50242-260

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phesgo (NDC 50242-260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Phesgo injection label showing pertuzumab, trastuzumab, and hyaluronidase-zzxf for subcutaneous injection. The label indicates strengths of 1,200 mg, 600 mg, and 30,000 units per 15 mL. It is a single-dose vial with directions to discard unused portions, labeled by Genentech.*

FDA Label Image

Principal Display Panel (15 mL Vial Carton)

Phesgo injection solution vial label showing the dosage strengths of pertuzumab 600 mg, trastuzumab 600 mg, and hyaluronidase-zzxf 20,000 units per 10 mL. Labeled for subcutaneous injection over 5 minutes. Single-dose vial, discard unused portion. Manufactured by Genentech, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.